dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Air medical transportation: How a 15-minute ride may cost $30,000, and how we can change it Reducing sky-high transport expenses

Canon's Vital Images wins DoD contract Maximum $100 million fixed‐price contract for radiology and imaging systems

Are you GDPR compliant? It's not just a question for EU-based companies Here are the top eight considerations

Security tightening at hospitals for patient safety A noticeable change is occurring at the front entrance to hospitals

Johnson & Johnson completes Auris Health deal The $3.4 billion acquisition could include additional payments up to $2.35 billion

Follow-up imaging study points to benefits of automated notification Raising the bar on manual callbacks

Change Healthcare files for IPO Could raise as much as $100 million, listing on Nasdaq

Mergers do nothing for quality of care, lower patient satisfaction, says study Based on 29 data points and the assessment of 16 processes of care

GE Healthcare IPO on hold as new deal takes spotlight Selling biopharma business to Danaher for over $21 billion

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Head of IBM Watson Health out after three hard years

by Thomas Dworetzky , Contributing Reporter
General Manager for IBM Watson Health Deborah DiSanzo is out, according to Stat News. The move comes at a time of some growing unease about its performance both clinical and business.

DiSanzo will join a strategy team for IBM Cognitive Solutions, and Watson Health will be run on an acting basis by John Kelly, senior vice president for Cognitive Solutions and IBM Research, Stat News learned from unnamed current and former employees.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



The move was confirmed by the company. “John Kelly will continue leading Watson Health as we continue to grow and scale this successful business,” a spokesman told the publication.

DiSanzo joined Watson Health in 2015, having been CEO of Philips Healthcare.

Watson had been hit with negative publicity of late.

But after a number of such negative stories about the progress of IBM's AI efforts – notably including one in Stat News and another in the August 11 Wall Street Journal – Kelly pushed back.

“We at IBM have a lot to be proud of, including our pioneering work with Watson Health,” he wrote in his August 11 blog post. “Unfortunately, some media reports, including an August 11 story published by The Wall Street Journal, distort and ignore facts when suggesting IBM has not made 'enough' progress on bringing the benefits of AI to healthcare.”

The Stat piece had uncovered internal company documents said to show “multiple examples” of treatment recommendations that were wrong or unsafe.

The Wall Street Journal piece noted that "more than a dozen IBM partners and clients have halted or shrunk Watson’s oncology-related projects."

Kelly acknowledged that the company had made “a big bet” on healthcare – including Watson for Oncology, Watson for Clinical Trial Matching, and Watson for Genomics – and that although there have been some dropouts, in total, the systems are in 230 hospitals and health organizations worldwide. They've also doubled the number of patients reached to 84,000 in the first half of 2018.

“The first question we asked ourselves was, 'can Watson help oncologists make better decisions for their patients?'” Kelly said, noting that, “repeatedly, the answer has proven to be a resounding 'yes,' as demonstrated in both peer-reviewed research as well as regular feedback from those using these tools.”

Studies, previously reported, have shown success with the AI efforts, Kelly noted, arguing that, “to suggest there has been no patient benefit is to ignore both what we know the Wall Street Journal was told by a number of physicians around the world and these institutions’ own public comments.”
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED